Cargando…
Biochemical Manifestation of HIV Lipodystrophy Syndrome
OBJECTIVES: Highly active anti-retroviral therapy (HAART), including protease inhibitors (PI) have led to dramatic improvements in the quality and quantity of life in patients with acquired immunodeficiency syndrome (AIDS). However, a significant number of AIDS patients on HAART develop characterist...
Autores principales: | Ihenetu, Kenneth, Mason, Darius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Global Health and Education Projects, Inc
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948165/ https://www.ncbi.nlm.nih.gov/pubmed/27621962 |
Ejemplares similares
-
Cardiac Manifestations of Congenital Generalized Lipodystrophy
por: Sanon, Vani P., et al.
Publicado: (2016) -
Lipodystrophy and metabolic syndrome in Romanian HIV-infected adults
por: Arbune, M
Publicado: (2010) -
FRI054 Partial Lipodystrophy As A Manifestation Of Autoimmune Polyglandular Syndrome 1
por: Agarwal, Shubham, et al.
Publicado: (2023) -
Lipodystrophy in HIV patients: its challenges and management approaches
por: Singhania, Rohit, et al.
Publicado: (2011) -
Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
por: Bedimo, Roger
Publicado: (2011)